Condition (MeSH)
Rectocele
ClinicalTrials.gov lists 49 trials for Rectocele or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
49 of the 49 trials are tagged with Rectocele itself; the rest are tagged with a narrower condition beneath it.
When did Rectocele trials start? (22)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 3
- Phase 4
- Not applicable
- Observational
Top of scale: 5
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 1 |
| 2025 | 1 |
| 2024 | 3 |
| 2023 | 3 |
| 2021 | 5 |
| 2020 | 2 |
| 2019 | 2 |
| 2018 | 3 |
| 2017 | 2 |
| 2016 | 2 |
Showing 10 of 22 earlier years.
No forecast is made for this condition: it averages 1.8 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 3 trials still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Rectocele trials in? (4)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 3 | 2 |
| Phase 4 | 2 |
| Not applicable | 32 |
| Observational | 13 |
How many Rectocele trials are recruiting? (6)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 2 |
| Recruiting | 4 |
| Enrolling by invitation | 1 |
| Completed | 27 |
| Terminated | 4 |
Showing 5 of 6 statuses.
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Rectocele trials? (7)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Coloplast A/S | 2 |
| Ethicon Endo-Surgery (Europe) GmbH | 2 |
| ASTORA Women's Health | 1 |
| Duomed | 1 |
| Ethicon Endo-Surgery | 1 |
Showing 5 of 7 sponsors.
Which drugs are being tested for Rectocele? (1)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| Cefuroxime | 1 |
Which serious adverse events do Rectocele trials report? (10)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Extrusion | 24 | 1 |
| Prolapse | 14 | 1 |
| Incontinence | 6 | 1 |
| Perforation - bladder | 5 | 1 |
| Surgery/reoperation for mesh exposure | 5 | 1 |
Showing 5 of 10 adverse events.
Which publications cover Rectocele? (49)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Transanal minimally invasive (TAMIS) mucosal resection with muscular plication for patients with obstructed defecation syndrome-A prospective pilot study. | Techniques in coloproctology | 2025 | Yes |
| Outcomes of laparoscopic ventral mesh rectopexy versus trans-vaginal repair in management of anterior rectocele, a randomized controlled trial. | Techniques in coloproctology | 2025 | Yes |
| Descent and hypermobility of the rectum in women with obstructed defecation symptoms. | International urogynecology journal | 2020 | Yes |
| Assessment of anal sphincter distensibility following the STARR procedure: a pilot study. | Acta chirurgica Belgica | 2020 | Yes |
| Functional Outcome and Sexual-Related Quality of Life After Transperineal Versus Transvaginal Repair of Anterior Rectocele: A Randomized Clinical Trial. | Diseases of the colon and rectum | 2020 | Yes |
Showing 5 of 49 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: prevalence, rare-disease identity, and sub-conditions in mesh.